Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Stock Quote Today & Recent News Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Healthcare Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:VM)

Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite

TheNewsWire 7 days ago

Voyageur Commences Testing of Innovative Barium Contrast Product Line in Human Radiology Scans, Paving the Way for Near-Term Market Launch

TheNewsWire 9 days ago

Canadian Investment Regulatory Organization Trade Resumption - VM

Canada NewsWire December 20, 2024

Voyageur Pharmaceuticals Ltd. Signs Letter of Intent with Global Contrast Imaging Company to Expand Market Reach and Product Portfolio

TheNewsWire December 20, 2024

Voyageur Announces Closing of Final Tranche of Private Placement

TheNewsWire December 18, 2024

Voyageur Announces Closing of First Tranche of Private Placement

TheNewsWire December 3, 2024
View More News ››

Opinion & Analysis (TSXV:VM)

Progress for radiology drugs and medical imaging company

Shoran Devi June 12, 2023

Health Canada Approvals Set Stage for Revenue Generation

Dave Jackson February 25, 2021

From the Earth to the Bottle

Dave Jackson January 21, 2020

VIDEO: High Grade Barite Producer

BTV-Business Television May 18, 2017
View More Opinion ››

Bullboard Posts (TSXV:VM)

ASK and BID at 0,165 now and we're going to 0,20

First step, 0,20 before 0,30. Probably ten bagger or more after 6 months just before FDA accept the results of the actual study. The...
sylvain_007 - 21 minutes ago

RE:RE:RE:RE:Now ask at 0,16

Now it,s to low you have to UP your bid at 0.16 minimum.
sylvain_007 - 26 minutes ago

RE:RE:RE:Now ask at 0,16

My 55K is still on the bid at 0.145, a little bit of effort please.
Budlight1971 - 1 hour ago

RE:Strong finish. Last 10 trades

Thank you for the posting.....someone bought 21 shares @ .165 as the last trade of the day.... Remaining cautiously optimistic......
WarrantOfficer - 1 hour ago

Strong finish. Last 10 trades

Recent Trades - Last 10 of 71 More trades... Time ET Ex Price Change ...
whitenorth72 - 16 hours ago

RE:RE:Now ask at 0,16

Always a good sign when the sales go off on the ask . The late volume was decent and it closed on the day high. Still imo way under where...
postie1 - 17 hours ago
View more Bullboard ››

Connect with V.VM

follow v.vm on


PRODUCTS PIPELINE CARBON DRUG PROJECT WHITE PAPER CASE STUDIES MANAGEMENT PRESENTATION

Voyageur Pharmaceuticals Deck 2024

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1